WilliamMuuseMD

Oncology • Rochester, NY

Twin Tiers Oncology PLLC

Join to view full profile

Dr. Muuse is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Muuse's full profile

Already have an account?

Office
601 Elmwood Ave
Rochester, NY 14642
Phone+1 585-275-5863

Fax+1 585-273-5761

Education & Training

Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 1989 - 1991
New York Downtown HospitalResidency, Internal Medicine, 1986 - 1989
University of Newcastle Upon Tyne Faculty of MedicineClass of 1985

Certifications & Licensure

NY State Medical License 1989 - 2024
PA State Medical License 2008 - 2018
CT State Medical License 1991 - 1992
NJ State Medical License 1988 - 1991
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 1997

Clinical Trials

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

33 citations
A study of lymphoma of large granular lymphocytes with modern modalities: Report of two cases and review of the literature
Tsieh Sun, Philip Schulman, Jonathan E. Kolitz, Myron Susin, Judith Brody
American Journal of Hematology. 1992-06-01

Professional Memberships

American College of Physicians - ACP
Fellow